報價延遲最少15分鐘:2026/04/26 08:32 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
16.8 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.66/-0.72
|
|
企業價值
641.46M
|
| 資產負債 |
|
每股賬面淨值
0.56
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
99.99M
|
|
每股收益
1.77
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads,depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care. |
